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Purpose: Great variation exists in the age of onset of symptoms and the severity of disease at a given age in patients with
retinitis pigmentosa (RP). The final pathway for this disease may involve apoptotic photoreceptor cell death. Telomere
length is associated with biologic aging, senescence, and apoptosis. We evaluated whether the length of telomeres in
leukocytes correlated with the severity of RP in patients with the Pro23His rhodopsin mutation who have shown marked
heterogeneity in disease severity.
Methods: We evaluated 122 patients with the Pro23His rhodopsin mutation. The patients’ retinal function was stratified
according to their 30-Hz cone electroretinogram (ERG). The length of telomeres in leukocytes was measured by the
quantitative real time polymerase chain reaction (qRT–PCR) method in the 15 patients with the highest age-adjusted 30-
Hz ERG amplitudes and in the 15 patients with the lowest amplitudes.
Results: Mean leukocyte telomere length was similar in the 15 patients with the highest cone ERG amplitudes (median:
0.40 units; interquartile range 0.36–0.56) and the 15 patients with the lowest cone amplitudes (median: 0.41 units; inter
quartile range 0.34 −0.64; p=0.95).
Conclusions: We found no evidence for an association between telomere length and the severity of RP as monitored by
the cone ERG in patients with the Pro23His rhodopsin mutation.
Retinitis pigmentosa (RP) is a group of inherited retinal
degenerations  with  progressive  photoreceptor  cell  death
typically causing night blindness, constricted visual fields,
and in later stages, a decrease in visual acuity. As the condition
progresses,  the  cone  electroretinogram  (ERG)  amplitude
decreases. Mutations in the rhodopsin gene (RHO; OMIM ID:
+180380) account for about 25% of the dominantly inherited
RP cases and less than a few percent of recessively inherited
cases [1-4]. The Pro23His mutation is the most frequently
reported  rhodopsin  mutation  in  the  United  States  [5],
accounting for about 8.5% of all dominant RP cases or about
1/3  of  those  with  a  dominant  rhodopsin  mutation  [6].
Interfamilial and intrafamilial variation in disease severity
among patients with this mutation have been described [7,8],
suggesting  that  factors  besides  the  primary  gene  defect
contribute to the disease.
Telomeres are structures at the ends of chromosome arms
consisting  of  tandem  repeats  of  the  nucleotide  sequence
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TTAGGG. These repetitive elements stabilize chromosomes
by preventing fusion with other chromosome ends and by
impeding degradation of coding DNA [9-11]. Short telomere
length has been associated with apoptosis [12-14]. Telomere
length is dependent on the number of previous cell divisions
and, thus, decreases with age. This decrease is compensated
in part by telomerase, which adds TTAGGG tandem repeats
to the 3′ end of the DNA strand [15-19]. Telomere length is
highly  variable  among  individuals,  and  this  variation  is
detectable at birth [20-22]. Telomere lengths are similar in
different tissues of the same individual, so the analysis of one
cell  type  (e.g.,  leukocytes)  reflects  the  telomere  size
throughout that individual [23,24].
Previous  studies  have  shown  an  inverse  relationship
between leukocyte telomere length and the occurrence of age-
related  diseases  such  as  chronic  heart  failure  [25]  and
dementia  [26].  Shorter  telomere  length  has  also  been
associated with disease severity [27].
In  this  study  we  evaluated  the  possible  association
between  telomere  length  and  the  severity  of  RP.  We
hypothesized that individuals with shorter telomere lengths
may  have  more  severe  photoreceptor  degeneration.  We
evaluated 122 patients who had autosomal dominant RP due
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592to the Pro23His mutation and selected 15 patients with the best
preserved  retinal  function  and  the  15  who  had  the  least
preserved retinal function. Telomere length was compared
with the loss of retinal function as indicated by the amplitude
of the 30-Hz cone ERG.
METHODS
Patient selection: This study conformed to the Declaration of
Helsinki and was approved by the Institutional Review Boards
of Harvard Medical School and the Massachusetts Eye and
Ear Infirmary and the Human Subjects Committee of the
Harvard  School  of  Public  Health.  Informed  consent  was
obtained from all patients. We evaluated 122 RP patients
previously found to have the dominant mutation Pro23His in
RHO  [28].  Patients  were  recruited  from  the  files  of  the
Berman-Gund Laboratory, Harvard Medical School. Patients
had elevated final dark adaptation thresholds and reduced rod
ERGs;  all  had  attenuated  retinal  arterioles  and  most  had
intraretinal bone spicule pigment around the periphery. The
general health of the patients was good. Blood samples from
the patients were obtained through phlebotomy and leucocyte
DNA was isolated using a Phenol/Chloroform extraction.
Measurements  of  retinal  function:  Retinal  function  was
evaluated based on the ERG amplitude recorded in response
to  30-Hz  white  flashes.  Full-field  ERG  responses  were
obtained following pupil dilation using one drop of a solution
containing  10%  phenylephrine  hydrochloride  and  1%
cyclopentolate hydrochloride (Akorn, inc., Buffalo Grove, IL)
and 45 min of dark adaptation. ERGs were recorded with a
contact  lens  electrode  placed  on  the  cornea  topically
anesthetized  with  one  drop  of  0.5%  proparacaine
hydrochloride (Alcon Laboratories, Inc. Fort Worth, TX).
Responses below 10 μV were recorded with narrow band-pass
filtering and then computer averaged to increase the signal to
noise ratio as described previously [29,30]. Amplitudes were
averaged between the two eyes (when results from both eyes
were available) and adjusted for age and refractive error.
Telomere  lengths:  The  relative  telomere  lengths  were
determined  using  a  modified  quantitative  real  time
polymerase chain reaction (qRT–PCR) [31,32]. Briefly, the
7900 HT thermocycler (Applied Biosystems, Foster city, CA)
was used to obtain the relative length of telomeres, expressed
as the ratio between the repeat copy number of telomeres (T)
and a reference single-copy gene (S; 36B4 gene, chromosome
12). All samples were compared with the same reference DNA
sample.  This  method  has  been  shown  to  correlate  with
Southern blot measurements of telomere length [33,34].
For each reaction 5 ng of DNA were dried in the well of
a reaction plate and resuspended in 10 μl of PCR reaction mix,
which contained 1X Qiagen Quantitect Sybr Green Master
Mix, 2.5 mM of dithiothreitol, and primers. Primers for the
telomere reaction were 270 nM of the sense primer (GGT TTT
TGA GGG TGA GGG TGA GGG TGA GGG TGA GGG T)
and 900 nM of the antisense primer (TCC CGA CTA TCC
CTA TCC CTA TCC CTA TCC CTA TCC CTA). Primers
for the 36B4 reaction were 300 nM of the sense primer (CAG
CAA GTG GGA AGG TGT AAT CC) and 500 nM of the
antisense primer (CCC ATT CTA TCA TCA ACG GGT ACA
A). The temperature for the first 5 min was 95 °C; this was
followed by 40 cycles consisting of 15 s at 95 °C and 2 min
at 54 °C for the telomere reaction or 1 min at 58 °C for the
36B4 reaction. ABI 7900HT software calculated the cycle
threshold for the Telomere (T) and reference gene (S) for each
sample.  The  ratio  T:S  represented  the  relative  amount  of
telomere DNA compared to single copy DNA and therefore
corresponded to relative telomere length. All samples were
analyzed in triplicate and the coefficient of variation (CV),
describing the amount of repeat variability, was calculated.
Statistical analysis: We confined our analysis of telomere
length to sets of patients at the extremes of disease severity as
determined by cone 30-Hz ERG amplitudes. Individuals at the
extremes for a continuously variable trait (such as disease
severity)  provided  the  most  power  for  uncovering  the
responsible factors, since they are most likely to differ in the
level of the responsible factors or their frequency (see, for
example,  power  calculations  for  mapping  genes  for
quantitative traits [35]). First, the relative telomere lengths
(T:S ratios) in the high and low ERG amplitude groups were
compared by means of a two-tailed Mann–Whitney U test.
Second, a linear regression analysis compared the loge 30-Hz
ERG amplitude to the T:S ratio adjusting for age and refractive
error.  The  Spearman  correlation  was  used  to  test  the
association between age and telomere length. A p-value of
<0.05  was  considered  statistically  significant.  The
aforedescribed  calculations  were  performed  with  SPSS
version 14 software (SPSS, Chicago, IL) or with JMP, version
6 (SAS Institute, Cary, NC).
RESULTS
Patients: We ranked 122 patients with the RHO-Pro23His
mutation  according  to  their  mean  30-Hz  ERG  amplitude,
adjusted for age and refractive error. After excluding a few
outlier patients with respect to age, we selected the 15 with
the highest 30-Hz ERG amplitude and the 15 with lowest. The
15 patients with the least severe RP (i.e., those with the highest
ERG amplitudes) consisted of nine males and six females. The
15 patients with the most severe disease (i.e., those with the
lowest ERG amplitudes) comprised eight males and seven
females.  The  mean  age  at  time  of  phlebotomy  for  DNA
samples from these two groups was 46.7 years (range: 27–58)
and 45.1 years (range: 31–62), respectively. Many of the 122
patients were related to others in this set. Of the 30 individuals
included in the analysis of the least and most severely affected,
14 were first degree relatives (siblings). An additional nine
individuals were also related to others in the analysis set but
were more distantly related. Among the first degree relatives,
four sets of two siblings appeared in the group with high ERG
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in the group with low ERG amplitudes (most severe), and one
sibship was split among the groups with two siblings in the
most severe group and one in the least severe group. Seven
patients were not related to any of the 30 extreme patients in
the in the analysis set. No unaffected controls were included
since we were only interested in the variation of telomere
length  related  to  disease  severity  within  this  group  of
Pro23His mutants. For patient characteristics and individual
results, see Table 1.
Analysis of the relative telomere lengths: The coefficient of
variation  in  our  study  was  satisfactorily  low with 1.27%
for the  T  assay  and   0.64%  for  the  S assay.    Spearman's
TABLE 1. PATIENTS INCLUDED IN HIGH AND LOW ERG AMPLITUDE GROUPS.
Sample          Family




ERG (μV) T/S ratio
High ERG amplitude group
218–288 5938 218–289 f 34 81 0.430198
001–191 1566 - m 38 76.0* 0.537613
218–289 5938 218–288 m 41 69.5 0.557743
226–1070 6149 226–1063 m 49 67.5 0.364527
226–1063 6149 226- 1070 m 51 51.5 0.350156
226–007 5850 218–005, 218–002 f 56 50 0.756707
218–309 6281 - f 46 46 0.376173
226–685 5970 001–299 m 56 42.5 0.397979
001–299 5970 226–285 m 58 41.1 0.341629
226–638 6149 - f 27 41 0.380276
218–243 6038 226–905 m 52 38 0.394993
226–905 6038 218–243 f 50 38 0.556106
001–385 6803 - m 46 35.3 0.519532
218–282 5938 - m 47 27.5 0.56872
218–280 E716 - f 49 12.6 0.311241
Low ERG amplitude group
001–007 6994 - f 34 2.3 0.364527
226–1426 5998 - f 42 1.04 0.769996
001–162 6653 - f 46 0.7 0.368992
218–003 5850 - m 38 0.65 0.412048
001–390 1509 - m 48 0.47 0.376173
218–005 5850 226–007, 218–002 m 55 0.3 0.608039
001–131 6281 - m 43 0.3 0.355099
218–255 5938 001–387, 218–031 f 32 0.23 0.586807
001–089 6149 - f 31 0.2* 0.799895
218–407 6888 - f 62 0.17 0.274106
218–060 1566 - f 62 0.16 0.340283
001–078 6038 - m 49 0.15 0.197481
001–387 5938 218–255, 218–031 m 34 0.13* 0.651994
218–002 5850 226–007, 218–005 m 60 0.12 0.430762
218–031 5938 218–255, 001–387 m 41 0.08 0.638473
This table lists the 30 Hz cone ERG amplitudes averaged across both eyes (Av30Hz ERG) for the 15 patients included in the
high ERG amplitude group (least severely affected) and the 15 patients included in the low ERG amplitude group (most severely
affected) along with the relative telomere lengths (ie. T/S ratio) obtained for each patient, the patient’s age at phlebotomy, their
gender and any first degree relatives also included in this study. Age ranges, gender distribution and T/S ratios were similar
between the two groups whereas the 30 Hz ERG amplitudes were on average nearly 100 fold greater in the high ERG group
than the low ERG group. Amplitudes marked with an * indicate that data was available for only one eye. All patients had reduced
or nondetectable rod ERG amplitudes (data not shown); some still had normal cone ERG amplitudes (normal range=50–125
μV).
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Sexcorrelation test showed a modest inverse relationship between
patient age and relative telomere length in the 30 patients
(r=-0.38; p=0.037). We found no significant difference in T:S
ratio between the 15 patients with the highest cone ERG
amplitudes (median: 0.40 units; interquartile range 0.36–0.56)
and the 15 patients with the lowest cone ERG amplitudes
(median: 0.41 units; interquartile range 0.34 −0.64; p=0.95)
using the Mann–Whitney U nonparametric test (Figure 1).
The results did not change when first degree relatives were
excluded from the analysis (n=22): T:S ratios of 11 patients
with  highest  cone  ERG  amplitudes  (median:  0.39  units;
interquartile range 0.36–0.56) were similar to the ratios of 11
patients with the lowest cone ERG amplitudes (median: 0.36
units;  interquartile  range  0.33  −0.64;  p=0.38).  Multiple
regression analysis of the total group of 30 patients, adjusting
for  age  and  refractive  error,  also  showed  no  significant
relation between loge 30 Hz-ERG amplitude and telomere T:S
ratio (t=-0.75; p=0.46).
DISCUSSION
The rhodopsin gene product is a transmembrane G-coupled
protein (opsin). It is found in the rod outer segments, and,
when bound with chromophore, mediates the initial steps of
the phototransduction cascade [36,37]. The RHO-Pro23His
mutation encodes a misfolded protein that aggregates within
the  endoplasmic  reticulum  [38,39]  and  seems  to  activate
apoptosis by the unfolded protein response (UPR) [40-42]. On
average, patients with the RHO-Pro23His mutation tend to
have milder disease compared to those with other rhodopsin
mutations  [43-47].  However,  there  is  great  variability  in
disease  severity  among  those  with  Pro23His,  and  this
variation can be objectively measured with ERGs [48].
Since  photoreceptors  in  RP  appear  to  die  ultimately
through apoptosis, and since cells with chromosomes with
short telomeres are prone to apoptosis, we hypothesized that
patients with short telomeres might have more severe disease
because their photoreceptors would more rapidly undergo
apoptosis  in  response  to  the  deleterious  effects  of  RHO-
Pro23His. To test this hypothesis, we confined our analysis to
sets  of  patients  at  the  extremes  of  disease  severity  as
determined by 30-Hz cone ERG amplitudes. We found no
evidence  for  an  association  between  telomere  length  and
severity of RP. However, a limitation of our analysis method
must  be  noted:  We  used  DNA  derived  from  dividing
leukocytes, since our cells of interest, the nondividing retinal
photoreceptors,  were  not  available  from  living  patients.
Although it is reported that telomere size is highly correlated
among tissues [49,50], it is known that dividing cells are
Figure 1. Relative telomere lengths in
Pro23His RP patients. Boxplot showing
no  difference  in  T:S  ratio’s  between
patients  with  high-  or  low  ERG
amplitudes. The shaded boxes indicate
the interquartile range. The horizontal
line  in  each  shaded  box  denotes  the
median,  and  the  error  bars  mark  the
upper and lower 95 percentiles of the
T:S ratio.
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595subject to changes in telomere length with the main known
factor being age. Since our groups of patients with mild and
severe RP were of about the same ages, and since the effect
of  age  is  relatively  small  compared  to  the  individual
differences in telomere length, we assumed that the telomere
length  in  the  peripheral  leucocytes  reflected  the  telomere
length  in  nondividing  photoreceptor  cells.  However,  a
possible difference in telomere lengths between these two cell
types  cannot  be  ruled  out.  Our  method  using  qRT–PCR
measurements of telomere lengths has successfully been used
in  other  studies  and  has  been  shown  to  correlate  to  the
Southern  blot  method  of  telomere  measurement  [51,52].
However both methods provide only an estimate of actual
telomere length.
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